No Provider Relationship
BritePear is operated by Cliff Johnson and Cheryl Johnson through C32X Studios, LLC, Vista, California. BritePear is a health education and personal transparency platform. It is not a medical practice, clinic, pharmacy, telehealth service, or licensed healthcare provider of any kind.
No content published on britepear.com, in any BritePear newsletter, in any BritePear application (including Tend by BritePear), or in any communication from BritePear creates, implies, or constitutes a physician-patient relationship, a pharmacist-patient relationship, a therapist-client relationship, or any other licensed professional relationship between BritePear and any visitor, subscriber, or user.
You have no licensed professional relationship with BritePear. We cannot diagnose you, treat you, prescribe anything to you, or give you individualized medical advice. We are sharing information, research, and our personal experience. Those are different things, and we do not blur that line.
Not Medical Advice
All content on britepear.com — including but not limited to articles, guides, protocol discussions, BriteBriefs, Cliff Pears It Down, Cheryl's Notes, community content, and any information within the Tend application — is provided for general educational and informational purposes only. It does not constitute medical advice, medical diagnosis, or medical treatment.
Specifically, the following content categories require your particular attention:
GLP-1 Medications
BritePear discusses semaglutide, tirzepatide, retatrutide, and other GLP-1 class medications in detail. This discussion is educational — explaining how these medications work, what clinical trials have found, and what Cliff and Cheryl have personally experienced. Nothing in this discussion constitutes a recommendation to begin, continue, modify, or discontinue any medication. GLP-1 medications require a prescription from a licensed prescriber in the United States and in most countries globally. Appropriate use, dosing, titration, and monitoring require individualized medical supervision.
Peptide Compounds — Research Use Only (RUO) Status
Many compounds discussed on BritePear — including BPC-157, TB-500, CJC-1295, Ipamorelin, AOD-9604, Semax, Selank, Epithalon, MOTS-c, and others — are sold legally in the United States only as Research Use Only (RUO) compounds. They are not FDA-approved for human therapeutic use. They have not completed the clinical trial process required for drug approval in the United States.
BritePear discusses these compounds in their educational and research context. BritePear does not advise, recommend, or encourage the purchase or use of any RUO compound for human therapeutic purposes. The discussion of these compounds on BritePear reflects the published research literature and, where noted, Cliff Johnson's personal self-directed research. These are not equivalent to a clinical recommendation.
Injectable compounds carry real risk. BritePear's SubQ Injection Guide and peptide protocol discussions describe techniques used by people who have made informed, self-directed decisions to explore these compounds. This information is provided for harm reduction and education — not as instruction or encouragement. Injectable compounds require sterile technique, proper reconstitution, appropriate storage, and awareness of contraindications. Incorrect use can cause serious injury or death. If you are considering injectable compounds, consult a qualified medical provider first.
The Gray Market and Compounding Pharmacies
BritePear's Our Journey page and other content honestly describes Cliff Johnson's personal experience navigating the gray market peptide space and obtaining medications abroad. This is personal transparency — not instruction, not endorsement, and not a recommendation for any reader to follow the same path. The legal and safety landscape for compounding pharmacies, gray market peptide sourcing, and obtaining prescription medications internationally involves significant complexity and risk. BritePear does not advise any reader to source medications or peptides through any specific channel. Readers bear sole responsibility for their own sourcing decisions.
Investigational Drugs
BritePear discusses retatrutide and other investigational compounds that are not FDA-approved and cannot be legally obtained through compounding pharmacies under current federal rules. This discussion is educational — providing context about clinical trial data for compounds that may eventually become approved therapies. It is not an endorsement of obtaining or using investigational drugs, and BritePear does not facilitate access to any investigational compound.
Personal Experience Is Clearly Labeled
BritePear distinguishes between three types of content:
- Published Research
- Peer-reviewed studies, clinical trial data, and scientific literature. Citations are provided. This represents the published scientific record — not BritePear's independent verification of every claim.
- Cliff Pears It Down / Cheryl's Notes
- Personal experience and observations from Cliff Johnson and Cheryl Johnson on their health journey. Clearly labeled. Not generalizable to other individuals. Not a clinical recommendation.
- Educational Context
- BritePear's synthesis and explanation of research, regulatory status, and health concepts. Intended to help readers understand the information landscape — not to direct individual health decisions.
When these types blur — when personal experience is presented without that label, or when synthesis is presented as established clinical guidance — that is an error, and we want to hear about it. Use the contact page to flag it.
FDA Status Notation
BritePear notes FDA approval status throughout the site. These notations reflect the regulatory status of compounds as understood at the time of publication. FDA status is subject to change. Compounds move between shortage list status, compounding eligibility, and approval status. BritePear makes reasonable efforts to keep this information current but makes no guarantee that any FDA status notation on the site reflects current regulatory status at the time you read it.
For current, authoritative FDA status on any compound, consult the FDA's official resources, USADA's Drug Reference Online, or a licensed pharmacist familiar with compounding regulations.
No Warranty; Limitation of Liability
All content on britepear.com is provided "as is" without any warranty of any kind, express or implied, including but not limited to warranties of accuracy, completeness, timeliness, merchantability, or fitness for a particular purpose.
To the fullest extent permitted by applicable law, BritePear, C32X Studios, LLC, Cliff Johnson, and Cheryl Johnson disclaim all liability for any direct, indirect, incidental, special, consequential, or exemplary damages arising from your use of or reliance on any content on this site — including but not limited to health outcomes, medication decisions, sourcing decisions, and use of any compound described here.
You assume full responsibility for any decision you make in connection with information obtained from this site. Health decisions involving medications, supplements, and especially injectable compounds carry inherent risk. BritePear's educational content does not reduce or eliminate that risk.
Medical Emergencies
If you are experiencing a medical emergency, call 911 or your local emergency number immediately. Do not use this website to seek guidance during a medical emergency. BritePear is not monitored for emergency communications and cannot provide emergency response of any kind.
If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988. If you believe you are having an adverse reaction to any medication or compound, contact Poison Control at 1-800-222-1222 (US) or seek emergency care immediately.
Consult a Qualified Provider
Nothing in this disclaimer is meant to discourage you from pursuing the information on this site. It is meant to be honest about what BritePear is and what it is not. We believe information should be free, honest, and accessible. We also believe that good information is a tool — and like any tool, it works best when used alongside proper professional guidance.
Before starting, stopping, or changing any medication, supplement, or health protocol — including anything discussed on BritePear — consult a qualified, licensed healthcare provider who knows your medical history. The Clarity section of this site is designed to help you have that conversation more effectively.
Questions about this disclaimer? Contact us at britepear.com/contact. We read every message.